Peiminine attenuates inflammatory bowel disease by suppressing TLR4 mediated NFƙB pathway: an integrated network pharmacology and experimental validation
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that certain natural products may have a role in alleviating inflammatory bowel disease. The specific compound peiminine is reported to suppress the TLR4 mediated NFƙB pathway, although the exact mechanisms and pathways involved in the disease are still being studied. Other factors, including intestinal neutrophils and macrophage extracellular trap-independent pathways, may also contribute to the disease's pathogenesis.